Xian KeliKang Pharmaceutical Technology

Xi'an Kelikang Pharmaceutical Technology is a Chinese pharmaceutical company that operates as a specialized research and development subsidiary of Xi'an Lijun Pharmaceutical. The company is primarily focused on the development of dermatological treatments and topical anti-infectives, most notably the Kelikang brand of clindamycin phosphate gel. This product is one of the most widely recognized treatments for acne vulgaris in the Chinese domestic market. Based in Xi'an, the company leverages its parent organization's extensive manufacturing infrastructure and distribution networks to commercialize its portfolio of small molecule therapeutics. Its business model integrates pharmaceutical technology transfer with the continuous optimization of topical drug delivery systems.